2 results
Approved WMOCompleted
Primary objective- To evaluate the efficacy of lenalidomide (RevlimidTM) in low/int-1 risk MDS with or without a treatment with Epo (NeoRecormonTM)/G-CSF (NeupogenTM) in terms of hematological improvement (HI) as defined by the modified response…
Approved WMORecruiting
Primary Objective:To examine the effect of ORIF versus nonoperative treatment of multiple simple fractured ribs on the rate of pneumonia within 30 days after trauma, in adult patients who sustained multiple simple fractured ribs.Secondary Objectives…